Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs Slide Insurance Holdings Inc. Common Stock (SLDE) Price & Performance

Medpace Holdings IncTrade
Slide Insurance Holdings Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs Slide Insurance Holdings Inc. Common Stock — how do they compare? Medpace Holdings Inc trades at $616.98 (market cap $17.21B), while Slide Insurance Holdings Inc. Common Stock trades at $25.56 (market cap $3.00B). The key difference: Medpace Holdings Inc is far larger — about 5.7× Slide Insurance Holdings Inc. Common Stock's market cap, and Slide Insurance Holdings Inc. Common Stock pays a 1.09% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Slide Insurance Holdings Inc. Common Stock for 0 Days on average.

MEDPSLDE
Market Cap
$17.21B$3.00B
Volume
311,2451,061,663
Sector
HealthFinancials
52-Week High
$630.19$26.48
52-Week Low
$393.42$14.38
Typical Hold Time
14 Days0 Days
Enterprise Value
$16.83B$1.80B
Dividend Yield
—1.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $609.89, down 1.64% today, with a bullish technical signal and strong support near $606. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $4.25 beating expectations of $3.98. Revenue grew to $2.53B in 2025, with a net income margin of 17.67%. Recent news highlights CEO stock sales and institutional position adjustments.

Outlook remains positive with a consensus price target of $620.44, offering modest upside. Key risks include high valuation multiples and insider selling. Earnings growth and sector demand are primary catalysts, but investor caution is warranted given elevated P/E and P/B ratios.

Slide Insurance Holdings Inc. Common Stock

SLDE trades at $25.50, down slightly (-0.12%) on the day, with strong fundamental metrics including a P/E of 6.16 and net income margin of 40.02%. The company has consistently beaten earnings expectations in recent quarters, with Q3 2026 results scheduled for October 27, 2026. Revenue growth from $1.16B in 2025 to projected $1.4B in 2026 demonstrates solid business momentum, supported by expanded insurance offerings in key markets.

The stock presents attractive value with strong profitability and analyst support (80% buy ratings), though hurricane exposure in Florida remains a key risk. Current price sits near consensus target of $25.00, suggesting limited near-term upside but solid fundamentals for long-term investors. Management's share repurchase program and dividend initiation provide additional shareholder value support.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MEDP

No sentiment data available yet.

SLDE
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP →

About Slide Insurance Holdings Inc. Common Stock

Slide Insurance Holdings, Inc. is a technology-enabled insurance company based in Florida that underwrites coastal specialty personal lines insurance, including homeowners and condominium unit owner policies, and also provides reinsurance and insurance agency services.

Read more on SLDE →